Immix Biopharma, Inc. (IMMX) stock
IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.20−0.28 (-3.74%)
Close on Nov 17, 2026Market cap $515.08MP/E –Yield –
Immix Biopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Immix Biopharma's market cap was $619.50M on Nov 11, 2026, against $140.40M a year earlier. Over the last 5 years it ranged from $12.02M to $1.00B, with a median of $55.70M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $619.50M | +258.6% |
| 2025 | Dec 31, 2025 | $172.78M | +185.8% |
| 2024 | Dec 31, 2024 | $60.46M | -55.4% |
| 2023 | Dec 29, 2023 | $135.69M | +325.5% |
| 2022 | Dec 30, 2022 | $31.89M | +165.4% |
| 2021 | Dec 31, 2021 | $12.02M | – |
See a number that looks wrong?